KalVista Pharmaceuticals, Inc.

KALVNASDAQHealthcare● Active

$26.95

+$0.00(+0.00%)

Market Cap$1.4B

P/E Ratio—

52W High$26.98

52W Low$9.83

Avg Volume3.4M

Open$26.96

Beta-0.11

Overview

KalVista Pharmaceuticals, Inc. (KALV) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KALV · as of Jul 10, 2025

Latest filing snapshot

270

+120+80.00%vs prior year

KalVista Pharmaceuticals, Inc. (KALV) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-04-30·Full-time · Global

Total Employees

270

Change (1Y)

+120

Growth % (1Y)

+80.00%

Revenue / Employee

$272.7K

Net Income / Employee

$-608.5K

Market Cap

$1.4B

KALV Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-07-10	2025-04-30	270	+120	+80.00%
2024-07-11	2024-04-30	150	+32	+27.12%
2023-07-10	2023-04-30	118	+13	+12.38%
2022-07-07	2022-04-30	105	+35	+50.00%
2021-07-13	2021-04-30	70	+14	+25.00%
2020-07-01	2020-04-30	56	+11	+24.44%
2019-07-16	2019-04-30	45	+12	+36.36%
2018-07-30	2018-04-30	33	+5	+17.86%
2017-07-27	2017-04-30	28	+28	—
2016-03-30	2015-12-31	0	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BCYC

Bicycle Therapeutics plc

305$291M #2

KALV

KalVista Pharmaceuticals, Inc.YOU

270$1.4B #3

ADCT

ADC Therapeutics S.A.

263$131M #4

FDMT

4D Molecular Therapeutics, Inc.

Olema Pharmaceuticals, Inc.

96$901M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KALV peer comparison

About KALV employees

KALV Employees · Headcount

KalVista Pharmaceuticals, Inc. (KALV) employee data is sourced from the annual SEC 10-K filing. As of 2025, KalVista Pharmaceuticals, Inc. had 270 full-time employees globally. Full-time employees only. Global consolidated headcount.

KalVista Pharmaceuticals, Inc. employs 270 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $272,656, reflecting the company's operational efficiency.

KalVista Pharmaceuticals, Inc.'s workforce increased by 120 (80.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

KalVista Pharmaceuticals, Inc.'s revenue per employee of $272,656 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

KALV Employees · 5 questions

As of the latest SEC 10-K filing (2025), KalVista Pharmaceuticals, Inc. had 270 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

KalVista Pharmaceuticals, Inc. employee counthow many employees does KalVista Pharmaceuticals, Inc. haveKALV total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-07-10